Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 2 Comparison <strong>Analysis</strong>, By Geography (2012 & <strong>2019</strong>) <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 3 Porter’s Five Forces <strong>Analysis</strong> For <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 4 <strong>Market</strong> Attractiveness For <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Geography, 2012<br />
FIG. 5 <strong>Global</strong> Bacterial <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By <strong>Disease</strong> Type, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 6 <strong>Global</strong> Viral <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By <strong>Disease</strong> Type, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 7 <strong>Global</strong> Parasitic <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, 2011-<strong>2019</strong> (USD Million)<br />
FIG. 8 Alere: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 9 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 10 Biomerica, Inc.: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 11 Biomerieux: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 12 Bio-Rad: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 13 Cepheid: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 14 Diasorin: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 15 Meridian Bioscience, Inc.: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 16 Quest Diagnostics: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 17 Trinity Biotech: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
List of Tables<br />
TABLE 1 <strong>Market</strong> Snapshot: <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> Products<br />
TABLE 2 <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 3 <strong>Global</strong> C.Difficile Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
Transparency <strong>Market</strong> Research<br />
12
Change language